Corresponding author: Pavlina Andreeva-Gateva ( pandreeva_gateva@outlook.com ) Academic editor: Georgi Momekov
© 2020 Pavlina Andreeva-Gateva, Dimitar Bakalov, Zafer Sabit, Radka Tafradjiiska-Hadjiolova.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Andreeva-Gateva P, Bakalov D, Sabit Z, Tafradjiiska-Hadjiolova R (2020) Aryl hydrocarbon receptors as potential therapeutic targets. Pharmacia 67(4): 311-315. https://doi.org/10.3897/pharmacia.67.e47298
|
Aryl hydrocarbon receptors (AhR) are regulators of the expression of cytochrome P-450 isoforms, mediating a wide variety of the effects of substances from the endogenous or exogenous origin, including those produced from the microbiome. An exciting new aspect of their activity is their localization in the brain and their potential to modulate the action of the immune system. AhR is emerging as an essential toxicological and therapeutic target for neuromodulation. Further studies are needed for elucidating their utility as drug-targets.
dioxin, indoles, toxicology, neuroprotection
Aryl hydrocarbon receptors (AhR) are ligand-activated receptors. They form nuclear heterodimer complexes with AhR-dependent nuclear translocator protein, and this complex binds to cis-xenobiotic responsive elements in the promoter region of AhR-responsive genes (
Many of those ligands have a much lower binding affinity for AhR than TCDD and structure-like toxic halogenated aromatic substances (
After being identified as mediators of the cellular response to xenobiotics, epidemiological studies in humans were conducted. The attention was focused on the pathological conditions of the immune system, lipid metabolism, epithelial integrity, porphyria manifestations, thymus involution, and neoplasms. The involvement of AhR inspired scientific researches (
The identification of AhR ligands and their well-described positive health effect and beneficial pharmaceutical properties has stimulated studies aimed at developing drugs for various tumors, immune and inflammatory diseases, and enhancers of hematopoietic stem cell production. In the development of drugs that target AhR, the aim is mainly directed to selective AhR modulators, in which the ligand exhibits tissue-specific agonist or antagonist activity (
Since AhRs are widely expressed in a number of tumors, molecules with antagonistic activity against AhRs could be considered as potential candidates for the treatment of such diseases. The most well-known AhR antagonist is alpha-naphtoflavone (Gasievicz and Rucci 1991). The potent AhR antagonist StemRegenin 1 has recently been developed as an inducer of human hematopoietic stem cell proliferation in vitro (
Throughout the many plant nutrients and chemicals of plant origin in the human diet, flavonoids are the most abundant and ubiquitous in fruits, vegetables, and wine. Quercetin, apigenin, and campherol, which are included in some foods, such as rose hips, linden flowers, honey, grapes, have been shown to exert agonist / antagonistic effects on AhR in various tissues (
AhR expression in vertebrate brain has recently been demonstrated by immunohistochemistry, with the brain stem, pineal gland, and some hypothalamic nuclei (including the suprachiasmatic nucleus controlling the circadian rhythm) having significantly elevated AhR levels compared to other areas of the brain (
All these data put the importance of AhR as a toxicological and pharmacological target. Further evaluation of the neuropharmacological potential of substances that bind and modulate AhR is needed.
With the support of the Council of Medical Sciences of the Medical University of Sofia, grant D-62/2019.